Publisher's Synopsis
This report addresses an analysis of the bioscience industry, its finance requirements and patterns in its valuation process. Examples are taken from well-known bioscience companies and relevant parallels are made with the pharmaceuticals industry.;The report explains how information flows in the market and describes a valuation model. It also provides a description and statistical analysis of the financing stages.
